About
Bispecific Antibodies for Immunology & Inflammation
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
196
By Phase
PHASE1: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06944925Lead Sponsor
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)
PHASE1Recruiting
98 participants
Started: May 8, 2025 · Completed: Mar 31, 2027
NCT06808477Lead Sponsor
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
PHASE1Recruiting
98 participants
Started: Feb 27, 2025 · Completed: Feb 6, 2027
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...